Gerresheimer sales expand on demand for insulin pens; AmerisourceBergen again snags VA contract; Azerbaijan wants labels in its language;

> Gerresheimer, the German pharmaceutical glass and plastics maker, reports a 14% revenue growth tied to higher sales of insulin pens and syringes. Story

> AmerisourceBergen Corp. ($ABC) and Cardinal Health ($CAH) were unable to wrest away from McKesson Corp. ($MCK) a $4 billion annual contract to supply drugs to Department of Veterans Affairs facilities which McKesson has held for 8 years. Article

> After July 1, Azerbaijan will ban any drugs into the country that do not have annotations in the Azerbaijani language. Story

> Genzyme is adding another 16,000 square feet to a plant in Northborough, MA, for storage of oxidizing gas to support demand since being acquired by Sanofi ($SNY). Story

> Henry Schein, the Melville, NY, supplier to medical, dental and veterinary practices has acquired from AUV Group AUV Veterinary Services, a Dutch company that supplies veterinary practices in Belgium and the Netherlands. Story

> St. Jude Medical's CEO Daniel Starks has embarked on a "scorched earth" defense against reports of deaths and injuries tied to defective leads on its heart defibrillators that may be backfiring. Story

> Lonza, the Swiss contract manufacturer and ingredient supplier, has named Richard Ridinger CEO following the ouster in January of Stefan Borgas after profits took a nosedive. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.